J2150 – Injection, mannitol, 25% in 50 ml
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2150
- Long description
- Injection, mannitol, 25% in 50 ml
- Short description
- Mannitol injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1986
- Last change
- October 1, 2025 – No change
- Termination date
- September 30, 2025
Frequently asked questions
What is HCPCS code J2150?
J2150 is a HCPCS Level II code for injection, mannitol, 25% in 50 ml. It was discontinued on September 30, 2025.
Does Medicare cover J2150?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2002 – Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003 – Injection, lidocaine hydrochloride, 1 mg
- J2004 – Injection, lidocaine hcl with epinephrine, 1 mg
- J2010 – Injection, lincomycin hcl, up to 300 mg
- J2020 – Injection, linezolid, 200 mg
- J2021 – Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060 – Injection, lorazepam, 2 mg
- J2062 – Loxapine for inhalation, 1 mg
- J2151 – Injection, mannitol, 250 mg
- J2170 – Injection, mecasermin, 1 mg
- J2175 – Injection, meperidine hydrochloride, per 100 mg
- J2180 – Injection, meperidine and promethazine hcl, up to 50 mg
- J2182 – Injection, mepolizumab, 1 mg
- J2183 – Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184 – Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185 – Injection, meropenem, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.